JP2004504379A5 - - Google Patents

Download PDF

Info

Publication number
JP2004504379A5
JP2004504379A5 JP2002514092A JP2002514092A JP2004504379A5 JP 2004504379 A5 JP2004504379 A5 JP 2004504379A5 JP 2002514092 A JP2002514092 A JP 2002514092A JP 2002514092 A JP2002514092 A JP 2002514092A JP 2004504379 A5 JP2004504379 A5 JP 2004504379A5
Authority
JP
Japan
Prior art keywords
pyrrolidine
carboxylic acid
mercapto
alkyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002514092A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004504379A (ja
JP3983663B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2001/007951 external-priority patent/WO2002008185A1/en
Publication of JP2004504379A publication Critical patent/JP2004504379A/ja
Publication of JP2004504379A5 publication Critical patent/JP2004504379A5/ja
Application granted granted Critical
Publication of JP3983663B2 publication Critical patent/JP3983663B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002514092A 2000-07-19 2001-07-10 メタロプロテアーゼインヒビターとしてのピロリジン誘導体 Expired - Lifetime JP3983663B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00114949 2000-07-19
PCT/EP2001/007951 WO2002008185A1 (en) 2000-07-19 2001-07-10 Pyrrolidine derivatives as metalloprotease inhibitors

Publications (3)

Publication Number Publication Date
JP2004504379A JP2004504379A (ja) 2004-02-12
JP2004504379A5 true JP2004504379A5 (enExample) 2005-02-24
JP3983663B2 JP3983663B2 (ja) 2007-09-26

Family

ID=8169226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002514092A Expired - Lifetime JP3983663B2 (ja) 2000-07-19 2001-07-10 メタロプロテアーゼインヒビターとしてのピロリジン誘導体

Country Status (15)

Country Link
US (3) US20020040146A1 (enExample)
EP (1) EP1303486A1 (enExample)
JP (1) JP3983663B2 (enExample)
KR (1) KR100613196B1 (enExample)
CN (1) CN100406439C (enExample)
AR (1) AR037990A1 (enExample)
AU (2) AU2001278479B2 (enExample)
BR (1) BR0112655A (enExample)
CA (1) CA2415740A1 (enExample)
MX (1) MXPA03000368A (enExample)
PA (1) PA8522301A1 (enExample)
PE (1) PE20020333A1 (enExample)
UY (1) UY26846A1 (enExample)
WO (1) WO2002008185A1 (enExample)
ZA (1) ZA200300170B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0112655A (pt) * 2000-07-19 2003-06-24 Hoffmann La Roche Derivados de pirrolidino como inibidores de metaloproteases
US7405234B2 (en) * 2002-05-17 2008-07-29 Bristol-Myers Squibb Company Bicyclic modulators of androgen receptor function
EP1558591B1 (en) 2002-10-07 2014-05-07 The Regents of The University of California Modulation of anxiety through blockade of anandamide hydrolysis
US7388027B2 (en) * 2004-03-04 2008-06-17 Bristol-Myers Squibb Company Bicyclic compounds as modulators of androgen receptor function and method
CN101376656A (zh) * 2007-08-30 2009-03-04 山东轩竹医药科技有限公司 培南衍生物
EP2234608A2 (en) 2007-12-11 2010-10-06 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
US8404866B2 (en) * 2008-09-03 2013-03-26 Florida State University Research Foundation Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors
RU2766579C2 (ru) 2015-07-02 2022-03-15 ХОРАЙЗОН ОРФАН ЭлЭлСи Цистеаминдиоксигеназа-резистентные аналоги цистеамина и их применение
BR112020014561A2 (pt) * 2018-01-17 2020-12-08 Migal - Galilee Research Institute Ltd. Nibidores inovadores da via metabólica da metionina
CN111825582B (zh) * 2020-08-12 2022-04-08 江西理工大学 一种以芳基磺酰氯为硫源合成β-硫代羰基化合物的方法
JP7904556B2 (ja) * 2022-11-25 2026-08-13 Ｎｔｔ株式会社 ベンゼンヘキサチオールの作製方法
CN120801563A (zh) * 2025-08-14 2025-10-17 陕西圣济康泽中药研究科技有限公司 一种检测西洋参中皂苷类物质的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
US4925838A (en) * 1988-03-18 1990-05-15 Fujisawa Pharmaceutical Company, Ltd. 3-pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid compounds
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
GB9301276D0 (en) * 1993-01-22 1993-03-17 Fujisawa Pharmaceutical Co Bicyclic compounds and their preparation
JP4182545B2 (ja) * 1994-02-25 2008-11-19 萬有製薬株式会社 カルバペネム誘導体
PT888340E (pt) * 1996-02-13 2002-12-31 Abbott Lab Derivados de acido 4-(benzo-1,3-dioxolil)pirrolidino-3-carboxilico como antagonistas de endotelina
BR9712792A (pt) * 1996-08-28 1999-12-14 Procter & Gamble Inibidores de metaloprotease bidentada.
BR9713465A (pt) * 1996-08-28 2000-03-28 Procter & Gamble Inibidores metalotprotease de amina cìclica sibstituìda
BR0112580A (pt) * 2000-07-19 2003-06-17 Hoffmann La Roche Compostos, composições farmacêuticas que contêm os mesmos, utilização desses compostos, processo para tratamento terapêutico e/ou profilático e processo para a preparação desses compostos
BR0112655A (pt) * 2000-07-19 2003-06-24 Hoffmann La Roche Derivados de pirrolidino como inibidores de metaloproteases

Similar Documents

Publication Publication Date Title
KR101004224B1 (ko) 인 함유 화합물 및 이의 용도
EP3661560B1 (en) Combination of atr kinase inhibitors and pd-1/pd-l1 inhibitors
TWI623528B (zh) 金屬酶抑制劑化合物、抑制金屬酶活性之方法、組合物、治療或預防植物疾病或病症之方法及其用途
JP2004504297A5 (enExample)
CN109863140A (zh) 3-氧代-2,6-二苯基-2,3-二氢哒嗪-4-甲酰胺
JP2012519179A5 (enExample)
JP2003528859A5 (enExample)
JP2005531516A (ja) 選択的ｅｐ４受容体アゴニストによる治療方法
RU2011146872A (ru) Производные пролина в качестве ингибиторов катепсина
JP2006504658A5 (enExample)
JP2005523248A (ja) ジペプチジルペプチダーゼｉｖの阻害剤
CN102438990A (zh) 取代的2-乙酰胺基-5-芳基-1,2,4-三唑酮和它的用途
JP2004536066A5 (enExample)
JP2006525276A5 (enExample)
JP2010533131A5 (enExample)
JP2006501306A5 (enExample)
WO2018153970A1 (en) Solid forms of 2-[(3r)-3-methylmorpholin-4-yl]-4-(1-methyl-1h-pyrazol-5-yl)-8-(1h-pyrazol-5-yl)-1,7-naphthyridine
US20030203890A1 (en) Method for treating nerve injury caused as a result of surgery
EP3558960B1 (en) Carboxylic acid aromatic amides as antagonists of bradykinin b1 receptor
US20100035888A1 (en) Diaryl Urea for Treating Pulmonary Hypertension
CN112638376B (zh) 取代的四氢环戊二烯并[c]吡咯、取代的二氢吡咯嗪、其类似物和其使用方法
CA2304647A1 (en) Method for preventing and treating hearing loss using sensorineurotophic compounds
CA2643005A1 (en) Imidazole-5-carboxylic acid derivatives,the preparation method therefor and the uses thereof
TW200522951A (en) New methods
RU2007102274A (ru) Пиперазиндионы как антагонисты рецептора окситоцина